Assessment of traditional Japanese Kampo effects in patients with chronic heart failure

Assessment of traditional Japanese Kampo effects in patients with chronic heart failure - Japanese Kampo medicine in chronic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012762

Enrollment

Registered

2014-01-06

Start date

2012-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic heart failure patients with cardiorenal syndrome: 1) Stable compensated patients with chronic heart failure classified as New York Heart Association (NYHA) functional class I-III. 2) Chronic heart failure Stage B or Stage C 3) Estimated glomerular filtration rate, eGFR < 65 mL/min/1.73 m2

Exclusion criteria

Exclusion criteria: Patients with: 1) intravascular volume depletion 2) indications for hemodialysis or acute kidney injury 3) sepsis or ongoing infection 4) alcohol and/or drug abuse 5) hepatic insufficiency 6) known allergy to the study medication or any of its components 7) enrollment in other clinical trials involving medical or device based interventions

Design outcomes

Primary

Measure	Time frame
Status of heart failure (NYHA classification, level of brain natriuretic peptide) Renal function (levels of serum creatinine, estimated glomerular filtration ratio)	—

Secondary

Measure	Time frame
Adverse effects	—

Countries

Japan

Contacts

Public ContactAtsushi Izawa

Shinshu University School of Medicine Department of Cardiovascular Medicine

izawa611@shinshu-u.ac.jp0263-37-3352

Outcome results